cleveland clinic glp 1 Could GLP-1 medications help slow cancer progression? A new study found those taking GLP-1s were less likely to develop stage IV disease in several cancer types, when compared to GLP-1 Receptor Agonists Didn't Worsen
Description
Gianina Flocco said in a statement
In the SCALE Obesity and Prediabetes trial, adults on Saxenda lost an average of around 8% of body weight over 56 weeks
While they are highly effective for chronic weight management, GLP-1 peptides were initially developed to manage Type 2 Diabetes and also offer significant cardiovascular and other metabolic health benefits
Our systematic review had a few limitations
:max_bytes(150000):strip_icc():focal(749x0:751x2)/cleveland-clinic-052226-1-2189041d28ba480a9103f4b37d2dd495.jpg)
Tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 receptor agonist (GLP-1 RA), has shown superior efficacy in glycemic control, weight loss and cardiometabolic outcomes compared to GLP-1 agonists alone
If you dont meet the metformin or A1C reduction criteria, Aetna may still approve your Ozempic prescription if you have Type 2 diabetes and another FDA-approved indication, such as cardiovascular disease
